You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(603127.SH):擬發行H股並申請在香港聯交所主板掛牌上市
格隆匯 07-23 15:56

格隆匯 7 月 23日丨昭衍新藥(603127.SH)公佈,公司第三屆董事會第二十一次會議決議,審議通過《關於公司發行H股股票並在香港上市及轉為境外募集股份有限公司的議案》;

經審議,公司董事會同意公司發行境外上市外資股(H股)並申請在香港聯合交易所有限公司(“香港聯交所”)主板掛牌上市;為完成此次發行並上市,同意公司轉為境外募集股份有限公司,並在公司董事會及其他授權人士及/或委託的承銷商(或其代表)決定的日期,根據H股招股説明書所載條款及條件,向符合相關條件的境外投資者及依據中國相關法律法規有權進行境外證券投資的境內合格投資者等發行H股股票

經審議,公司董事會同意公司發行境外上市外資股(H股)股票所得的募集資金在扣除發行費用後,將全部用於公司,可能包括(但不限於)用於擴大運營規模、項目投資建設、收購兼併、補充流動資金等。具體募集資金用途及投向計劃以H股招股説明書的披露為準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account